|
|
|
|||
|
Since
1977, Drug Information Center (DIC) have assessed
drugs on research. Assessment of drugs is demanded to efficacy, safety, and
other factors. We make an objective appraisal of the factors, and provide the
information to doctor, pharmacist and other medical professions. |
||||
|
|
Executive |
|
||
|
President |
Kunio
SUGIURA |
|||
|
Vice
president of DIC |
Hiroaki KONISHI |
|||
|
Staff |
||||
|
Director |
Hisashi IIJIMA, Ph.D. |
|||
|
Researcher |
Yumeka WASHIO |
|||
|
Commissioner |
Takao
AOYAMA, Ph.D. |
|||
|
Kazutoshi KOBAYASHI |
||||
|
Eriko SUGAYA |
||||
|
Shutaro YOKOTA |
||||
|
Office clerk |
Reiko ODA |
|||
|
1. Provision of Information (1) Drug information, Medical insurance, and associated information (2) Control over the Internet #
Website maintenance #
Information service by e-mail (3) Information service by FAX (4) Information
service to patient (5) Information service to pharmacist 2. Research Achievement (1) Evaluation of pharmacists' ability (2) Evaluation of clinical article (3) Formulation and evaluation of medical care information system (4) Formulation and evaluation of cooperation with regional medical Research of medical
pharmacy is demanded to scientific, ethical, and moral responsibility.
Particularly on ethical responsibility, human rights must be guaranteed. And
the research must abide by the pharmaceutical regulation, and other acts. And
so Ethical Review Board judge research of medical pharmacy. 4. Regional
Medical Liaison Office #
Coordinator of Drug
sheet of Chiba Alliance Medical Path-Stroke (CAMP-S) # System
of registration for home care pharmacy #
Training of physical assessment 5. Editorial Office Chiba
Pharmaceutical Association began to publish the Journal of Chiba
Pharmaceutical Association in 1956. The journal includes academic documents,
public affairs, and so forth. Editorial office edits the journal, and issue
at 11 times a year. 6. Risk Management In case of medical
accident, we support pharmacist with the lawyer. 7. Infection control The cooperation with the government and other organizations is important for infection control. DIC has created a manual for the novel influenza and the novel coronavirus so that community pharmacists can take appropriate infection control. Drug Information
Center, Chiba Pharmaceutical Association 9-2 Tonyacho, Chuo-ku, Chiba-shi, Chiba 260-0025, Japan |
||||
